Inactief instrument

Koers Alexza Pharmaceuticals, Inc. Nasdaq

Aandelen

slotkoers Nasdaq Andere beurzen
- ^USD	-

Alexza Pharmaceuticals : Reports Fourth Quarter and Year End 2015 Financial Results	28-03-16
Alexza Pharmaceuticals : to Report 2015 Year End Financial Results and Provide Company Update on Monday, March 28, 2016	15-03-16
Alexza Pharmaceuticals : Receives Positive Nasdaq Listing Determination	09-03-16
Alexza Pharmaceuticals : Confirms Grupo Ferrer Non-binding Letter of Intent	27-02-16
Alexza Pharmaceuticals : Reacquires U.S. Commercial Rights for ADASUVE® (loxapine) inhalation powder	24-02-16

Managers	Titel	Leeftijd	Van
Stacy Palermini DFI	Director of Finance/CFO	-	01-01-03
Tatjana Naranda PSD	President	-	01-01-05
Wolfgang Schmidt PRN	Corporate Officer/Principal	-	01-05-19

Besturend	Titel	Leeftijd	Van
Jorge Ramentol Massana BRD	Director/Board Member	-	21-06-16
Joan Fanés Trillo BRD	Director/Board Member	-	21-06-16
Sergio Ferrer-Salat Serra di Migni BRD	Director/Board Member	-	21-06-16

Sector

	Vaira. 1 jan.	Kapi.
VERTEX PHARMACEUTICALS INCORPORATED	+16,61%	122 mld.
REGENERON PHARMACEUTICALS, INC.	+17,75%	112 mld.
ARGENX SE	+17,23%	25,91 mld.
BIONTECH SE	-24,11%	19,33 mld.
GENMAB A/S	-18,56%	16,17 mld.
BEIGENE, LTD.	-18,47%	15,6 mld.
WUXI APPTEC CO., LTD.	-47,75%	14,65 mld.
SAREPTA THERAPEUTICS, INC.	+57,35%	14,34 mld.
NEUROCRINE BIOSCIENCES, INC.	+5,62%	14 mld.